143 related articles for article (PubMed ID: 15785879)
21. The BRAF gene is frequently mutated in malignant melanoma.
Stratton MR; Wooster RW; Futreal PA
J Drugs Dermatol; 2004; 3(5):573-5. PubMed ID: 15552615
[No Abstract] [Full Text] [Related]
22. Guilty as charged: B-RAF is a human oncogene.
Garnett MJ; Marais R
Cancer Cell; 2004 Oct; 6(4):313-9. PubMed ID: 15488754
[TBL] [Abstract][Full Text] [Related]
23. The RAF proteins take centre stage.
Wellbrock C; Karasarides M; Marais R
Nat Rev Mol Cell Biol; 2004 Nov; 5(11):875-85. PubMed ID: 15520807
[TBL] [Abstract][Full Text] [Related]
24. The long arm of BRAF V600E gets to mTORC1.
Lopez-Bergami P
Pigment Cell Melanoma Res; 2009 Jun; 22(3):244-5. PubMed ID: 19338646
[No Abstract] [Full Text] [Related]
25. Targeting intracellular signaling pathways as a novel strategy in melanoma therapeutics.
Smalley KS; Herlyn M
Ann N Y Acad Sci; 2005 Nov; 1059():16-25. PubMed ID: 16382039
[TBL] [Abstract][Full Text] [Related]
26. Heme oxygenase 1 facilitates cell proliferation via the B-Raf-ERK signaling pathway in melanoma.
Liu L; Wu Y; Bian C; Nisar MF; Wang M; Hu X; Diao Q; Nian W; Wang E; Xu W; Zhong JL
Cell Commun Signal; 2019 Jan; 17(1):3. PubMed ID: 30634993
[TBL] [Abstract][Full Text] [Related]
27. Lucky draw in the gene raffle.
Pollock PM; Meltzer PS
Nature; 2002 Jun; 417(6892):906-7. PubMed ID: 12087387
[No Abstract] [Full Text] [Related]
28. Recent progress in understanding the pathology of malignant melanoma.
Kuphal S; Bosserhoff A
J Pathol; 2009 Dec; 219(4):400-9. PubMed ID: 19771562
[TBL] [Abstract][Full Text] [Related]
29. Cancer: Melanoma troops massed.
Huang PH; Marais R
Nature; 2009 May; 459(7245):336-7. PubMed ID: 19458705
[No Abstract] [Full Text] [Related]
30. A Notch for noncoding RNA in melanoma.
Garraway LA
N Engl J Med; 2014 May; 370(20):1950-1. PubMed ID: 24827041
[No Abstract] [Full Text] [Related]
31. Taking the stress out of melanoma.
Martin MJ; Carling D; Marais R
Cancer Cell; 2009 Mar; 15(3):163-4. PubMed ID: 19249673
[TBL] [Abstract][Full Text] [Related]
32. DNA microarray analyses of melanoma gene expression: a decade in the mines.
Hoek KS
Pigment Cell Res; 2007 Dec; 20(6):466-84. PubMed ID: 17935490
[TBL] [Abstract][Full Text] [Related]
33. [Genetic markers of melanoma].
Tronov VA; Artamonov DN; Gorbacheva LB
Genetika; 2010 Feb; 46(2):168-79. PubMed ID: 20297650
[TBL] [Abstract][Full Text] [Related]
34. The Ludwig institute for cancer research Melbourne melanoma cell line panel.
Behren A; Anaka M; Lo PH; Vella LJ; Davis ID; Catimel J; Cardwell T; Gedye C; Hudson C; Stan R; Cebon J
Pigment Cell Melanoma Res; 2013 Jul; 26(4):597-600. PubMed ID: 23527996
[No Abstract] [Full Text] [Related]
35. Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma.
Old WM; Shabb JB; Houel S; Wang H; Couts KL; Yen CY; Litman ES; Croy CH; Meyer-Arendt K; Miranda JG; Brown RA; Witze ES; Schweppe RE; Resing KA; Ahn NG
Mol Cell; 2009 Apr; 34(1):115-31. PubMed ID: 19362540
[TBL] [Abstract][Full Text] [Related]
36. [Signal transduction in melanoma].
Yokoyama S
Seikagaku; 2013 Jun; 85(6):469-74. PubMed ID: 23875475
[No Abstract] [Full Text] [Related]
37. BRAF as a potential therapeutic target in melanoma and other malignancies.
Tuveson DA; Weber BL; Herlyn M
Cancer Cell; 2003 Aug; 4(2):95-8. PubMed ID: 12957284
[No Abstract] [Full Text] [Related]
38. A complex but promising therapy.
Ronai Z
Pigment Cell Melanoma Res; 2010 Apr; 23(2):151-2. PubMed ID: 20394679
[No Abstract] [Full Text] [Related]
39. Recent advances in melanoma biology.
Perlis C; Herlyn M
Oncologist; 2004; 9(2):182-7. PubMed ID: 15047922
[TBL] [Abstract][Full Text] [Related]
40. Differences in tumor initiation and progression of melanoma in the Braf
Zhai Y; Haresi AJ; Huang L; Lang D
Pigment Cell Melanoma Res; 2020 Jan; 33(1):119-121. PubMed ID: 31449725
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
